Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 34 Carcinoma, Non-Small-Cell Lung 26 Breast Neoplasms 26 Lung Neoplasms 24 Colonic Neoplasms 18 Head and Neck Neoplasms 16 Rectal Neoplasms 14 Prostatic Neoplasms 11 Sarcoma 10 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Neoplasms 7 Mouth Neoplasms 7 Melanoma 7 Esophageal Neoplasms 7 Adenomatous Polyposis Coli 7 Ovarian Neoplasms 6 Glioblastoma 6 Precancerous Conditions 5 Neuroblastoma 5 Liver Neoplasms 5 Central Nervous System Neoplasms 5 Carcinoma 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Oropharyngeal Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4

Interventions

ulipristal acetate 20 Uterine Myomectomy 19 telapristone acetate 18 vilaprisan 12 relugolix 12 Leuprolide 11 Uterine Artery Embolization 10 estradiol, norethindrone drug combination 9 asoprisnil 9 Estradiol 8 elagolix 7 Tranexamic Acid 7 Mifepristone 7 Bupivacaine 7 ulipristal 6 Norethindrone Acetate 6 Hysterectomy 6 Saline Solution 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Misoprostol 4 Letrozole 4 Vitamin B 6 3 Tablets 3 Surveys and Questionnaires 3 Sugars 3 Radiofrequency Ablation 3 Lidocaine 3 Hysteroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyoma × Celecoxib × Clear all

NCT01555073 2016-07-28

Preemptive Analgesia Following Uterine Artery Embolization

Northwestern University

Phase 4 Terminated

23 enrolled 6 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡